META-ANALYSIS
Add like
Add dislike
Add to saved papers

The results of surgical therapy for cryptorchidism: a literature review and analysis.

Journal of Urology 1995 September
PURPOSE: The literature was reviewed to consolidate the diverse success rates reported for orchiopexy.

MATERIALS AND METHODS: A total of 64 articles pertaining to 8,425 undescended testicles was reviewed and found to contain evaluable data. Success was defined as scrotal position and lack of atrophy.

RESULTS: Success rates by anatomical testicular position were 74% for abdominal, 82% for peeping and 87% for canalicular testes, and 92% for those located beyond the external ring. Success rates by procedure were 89% for inguinal, 67% for Fowler-Stephens, 77% for staged Fowler-Stephens, 81% for transabdominal, 73% for 2-stage and 84% for microvascular orchiopexy.

CONCLUSIONS: The significant failure rate for proximal testes suggests that efforts to improve orchiopexy should continue.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app